Celltrion Anticipates the Launch of its POCT Kit for COVID-19 in July 2020

 Celltrion Anticipates the Launch of its POCT Kit for COVID-19 in July 2020


  • Celltrion has completed the development of a point-of-care antigen testing kit for COVID-19 in collaboration with BBB. The POCT kit is a portable and overly sensitive device for use in rapid POC testing, thus supporting the early detection of COVID-19+ patients in clinical settings
  • Celltrion’s POCT kit demonstrated 95% sensitivity, utilizes lab-on-a-chip technology consisting of a microfluidic electrochemical biosensor to provide results within 15-20 min., while the company anticipates receiving a CE mark in EU later this month with its expected launch in July
  • Additionally, Celltrion has entered into a distribution agreement with Humasis to distribute and commercialize a rapid Ab diagnostic test globally this month. Both the companies will cooperate in the development of an upgraded RDT kit and a rapid antigen diagnostic test, for which Celltrion will apply its COVID-19 antibody-antiviral technology to enhance detection sensitivity

Click here to read full press release/ article | Ref: Celltrion | Image: BioProcess International

Related News: Celltrion to Launch Rapid Self-Testing Kit and Accelerates the Development of Treatment Against COVID-19

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post